A drug already on the market for 20 years effectively reduced nodules associated with Dupuytren’s disease in a mid-stage trial, researchers said. Patients receiving intranodular injections of adalimumab (Humira) showed significant declines in nodule hardness and volume over 18 months, whereas these remained stable or increased in a saline-treated control group, reported Jagdeep Nanchahal, MBBS, […]

If you’re considering a career change from pharma to biotech, you’ll be happy to hear that it might be more common than you think. To navigate a career change from pharma to biotech (or the other way around), make the most of your soft skills to achieve success.  Resiliency, being prepared for sudden changes and accepting the […]

An estimated 100 million people suffer from alcohol abuse disorder (AUD) worldwide with health authorities citing the condition as a leading cause of death in young people. But the market for pharmaceutical treatments targeting AUD has been relatively stagnant, and many current options carry significant tolerability issues. However, after decades of relative standstill, the market […]